Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zila

This article was originally published in The Tan Sheet

Executive Summary

Douglas Burkett, PhD, named VP-pharmaceuticals & development May 2. Burkett will oversee Zila's Innovative Swab Technologies division and Zila Technical Operations, as well as Zila Pharmaceuticals, which includes the Phoenix-based company's professional and consumer pharmaceuticals businesses. Burkett began his career at Zila in 1995 as manager of research & manufacturing; he most recently served as VP of the Technical Operations division. Zila's products include Zilactin canker sore and oral pain remedies...

You may also be interested in...



Zila Ester-C Ad Campaign Features Radio, TV Spots Debuting This Fall

Zila, Inc. division Inter-Cal Nutraceuticals will launch a nine-month national advertising campaign this fall for its Ester-C supplement ingredient

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel